Evidence map›Paper›PMID 36819538›Full record

ArticleAnnals of translational medicine2023

Kang Li, Rulan Ma, Lei Meng, Qing Wang, Jun Cao, Dawei Yuan, Tuanhe Sun, Li Kang, Nan Hao, Haonan Wang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Kang LiDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Rulan MaDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Lei MengDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Qing WangDepartment of Surgery, University of Virginia, Charlottesville, VA, USA.
Jun CaoDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Dawei YuanDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Tuanhe SunDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Li KangDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Nan HaoDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Haonan WangDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Kun ZhuDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
First Affiliated Hospital of Xi'an Jiaotong University · CNUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatitis B virus X protein ( Methods: Lentiviruses were constructed and transfected into GC cells to upregulate or downregulate gene expression. The expressions of proteins in GC cells or tumor tissues were assessed by quantitative reverse transcription polymerase chain reaction (RT-qPCR), Western blotting, immunohistochemistry (IHC) assay, or the Gene Expression Profiling Interactive Analysis (GEPIA) database. Cell proliferation was assessed via methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay, Celigo cell counting assay, cell cycle analysis, and colony formation assay. Cell apoptosis was assessed by flow cytometry. The apoptosis-related proteins were evaluated using the human apoptosis antibody array. GC cell migration was detected by scratch wound-healing assays and Transwell migration assays. Potential downstream molecules were identified by the human GeneChip assay combined with bioinformatics analysis. Results: We found that Conclusions:

Indexed as

CDK6gastric cancer (GC)therapeutic targettumor promoterXTP1

Identifiers

PMID36819538
PMCPMC9929835
OpenAlexW4320007611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.